Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics
Conclusions The HOPE-3 trial will provide new information on cholesterol and BP lowering in intermediate-risk populations with average cholesterol and BP levels and is expected to inform approaches to primary prevention worldwide (HOPE-3 ClinicalTrials.gov NCT00468923).
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Crestor | Heart | Heart Attack | Heart Failure | Hydrochlorothiazide | Legislation | Rosuvastatin | Statin Therapy | Stroke | Study | Women